Nanoparticles and Their Applications in Biology
Abstract
Nanoparticles are materials with dimensions generally ranging from 1 to 100 nm and have attracted considerable attention because their physicochemical properties differ from those of bulk materials. Their small size, high surface-area-to-volume ratio, optical and magnetic properties, and modifiable surfaces make them valuable tools in biological research and medicine. Nanoparticles have been investigated for applications in drug delivery, gene delivery, bioimaging, biosensing, cancer therapy, antimicrobial treatment, tissue engineering, and regenerative medicine. Different types of nanoparticles, including metallic, magnetic, polymeric, lipid, silica, and semiconductor nanoparticles, possess distinct properties that can be tailored for specific biological applications. In particular, lipid nanoparticles have become important carriers for nucleic acids, while gold and magnetic nanoparticles have shown promise in imaging and cancer therapy. Despite their potential, issues related to toxicity, biodistribution, stability, immune responses, and large-scale manufacturing remain important challenges. This article reviews the major types of nanoparticles and their applications in biology, with emphasis on their therapeutic, diagnostic, and research uses.
References
2. De Jong WH, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133-149.
3. Jain KK. Nanotechnology in clinical laboratory diagnostics. ClinChimActa. 2005;358(1-2):37-54.
4. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58(14):1532-1555.
5. Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA. The golden age: gold nanoparticles for biomedicine. ChemSoc Rev. 2012;41(7):2740-2779.
6. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83.
7. Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 2003;36(13).
8. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1-18.
9. Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6:1078-1094.
10. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science. 1998;281(5385):2013-2016.
11. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. AngewChemInt Ed Engl. 2007;46(40):7548-7558.
12. Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev. 2005;57(15):2106-2129.
13. Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int J Pharm. 2021;601:120586.
14. Nag OK, Delehanty JB. Active cellular and subcellular targeting of nanoparticles for drug delivery. Pharmaceutics. 2019;11(11):543.
15. Lafuente-Gómez N, Latorre A, Milán-Rois P, Rodriguez Diaz C, Somoza Á. Stimuli-responsive nanomaterials for cancer treatment: boundaries, opportunities and applications. ChemCommun. 2021;57:13662-13677.
16. Kaur H, Shorie M. Nanomaterial based aptasensors for clinical and environmental diagnostic applications. Nanoscale Adv. 2019;1:2123-2138.
17. Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J HematolOncol. 2021;14:85.
18. Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg. 2021;8:34.
19. Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7(12):779-786.
20. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101-124.
Copyright © Author(s) retain the copyright of this article.

.